相关实验视频

Updated: Sep 11, 2025

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

由ITPRIPL1介导的免疫逃避机制及其在质瘤中的预后影响

Zou Xiaoyun¹, Ye Wenhao¹, Wu Huan¹

¹Anhui Engineering Research Center for Neural Regeneration Technology and Medical New Materials, Bengbu Medical University, Bengbu, China.

Brain and behavior

|August 12, 2025

概括

ITPRIPL1是一种新型连接体,抑制T细胞免疫力,并阻碍质瘤中药物的疗效,促进瘤生长和预后不佳. 了解这种作用对于新的质瘤免疫疗法至关重要.

科学领域:

神经瘤学神经瘤学
免疫学免疫学免疫学
基因组学就是基因组学.

背景情况:

质瘤是一种致命的中枢神经系统癌症.
一个CD3ε抑制器连接体IT জৈPRIPL1,抑制T细胞激活,有助于质瘤免疫逃避.
ITPRIPL1 是一种潜在的质瘤免疫治疗标.

研究的目的:

研究ITPRIPL1在质瘤中的作用和预后意义.
分析ITPRIPL1与临床病理特征,免疫透和药物敏感性的关联.
基于ITPRIPL1表达的基质瘤患者生存预测模型的开发.

主要方法:

对ITPRIPL1表达和临床相关性的TCGA,CGGA和GEO数据集的分析.
免疫透分析和药物敏感性分析.
机器学习模型开发 (SuperPC) 和用于预后评估的名ogram构建.

主要成果:

提升ITPRIPL1表达与更高的结质瘤等级和更糟糕的结果相关.
ITPRIPL1与减少的T细胞和增加的M2巨细胞有关,创造了一个免疫抑制的环境.
ITPRIPL1显示了与AZD8055等药物潜在的治疗联系;开发了一个预后名录.

结论:

ITPRIPL1抑制T细胞免疫力,并在质瘤中促进免疫抑制性瘤微环境.
ITPRIPL1对抗瘤药物的疗效产生负面影响,促进质瘤的进展.
ITPRIPL1作为潜在的预后生物标志物和质瘤的治疗点.

关键词:

这就是ITPRIPL1的原因.质瘤质瘤是一种免疫透免疫透是什么?机器学习是机器学习.预后生物标志物预后生物标志物

更多相关视频

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

相关概念视频

Regulation of the Unfolded Protein Response

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...